These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 10706620)
1. Mantle cell lymphoma is characterized by inactivation of the ATM gene. Schaffner C; Idler I; Stilgenbauer S; Döhner H; Lichter P Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2773-8. PubMed ID: 10706620 [TBL] [Abstract][Full Text] [Related]
2. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia. Schaffner C; Stilgenbauer S; Rappold GA; Döhner H; Lichter P Blood; 1999 Jul; 94(2):748-53. PubMed ID: 10397742 [TBL] [Abstract][Full Text] [Related]
3. Development of a mantle cell lymphoma in an ATM heterozygous woman after occupational exposure to ionising radiation and somatic mutation of the second allele. Briani C; Schlotter M; Lichter P; Kalla C Leuk Res; 2006 Sep; 30(9):1193-6. PubMed ID: 16387360 [TBL] [Abstract][Full Text] [Related]
4. Peripheral blood complete remission after splenic irradiation in mantle-cell lymphoma with 11q22-23 deletion and ATM inactivation. Filippi AR; Franco P; Galliano M; Ricardi U Radiat Oncol; 2006 Sep; 1():35. PubMed ID: 16956411 [TBL] [Abstract][Full Text] [Related]
5. ATM mutations in cancer families. Vorechovský I; Luo L; Lindblom A; Negrini M; Webster AD; Croce CM; Hammarström L Cancer Res; 1996 Sep; 56(18):4130-3. PubMed ID: 8797579 [TBL] [Abstract][Full Text] [Related]
6. ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances. Camacho E; Hernández L; Hernández S; Tort F; Bellosillo B; Beà S; Bosch F; Montserrat E; Cardesa A; Fernández PL; Campo E Blood; 2002 Jan; 99(1):238-44. PubMed ID: 11756177 [TBL] [Abstract][Full Text] [Related]
7. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia. Vorechovský I; Luo L; Dyer MJ; Catovsky D; Amlot PL; Yaxley JC; Foroni L; Hammarström L; Webster AD; Yuille MA Nat Genet; 1997 Sep; 17(1):96-9. PubMed ID: 9288106 [TBL] [Abstract][Full Text] [Related]
8. Absence of ATM deletions in 16 cases of splenic marginal-zone B-cell lymphoma (SMZBCL). Salido M; Astier L; Puigdecanet E; Espinet B; Florensa L; Solé F Haematologica; 2003 Nov; 88(11):ELT33. PubMed ID: 14607769 [TBL] [Abstract][Full Text] [Related]
9. Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma. Greiner TC; Dasgupta C; Ho VV; Weisenburger DD; Smith LM; Lynch JC; Vose JM; Fu K; Armitage JO; Braziel RM; Campo E; Delabie J; Gascoyne RD; Jaffe ES; Muller-Hermelink HK; Ott G; Rosenwald A; Staudt LM; Im MY; Karaman MW; Pike BL; Chan WC; Hacia JG Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2352-7. PubMed ID: 16461462 [TBL] [Abstract][Full Text] [Related]
10. The ATM gene in the pathogenesis of mantle-cell lymphoma. Stilgenbauer S; Schaffner C; Winkler D; Ott G; Leupolt E; Bentz M; Möller P; Müller-Hermelink HK; James MR; Lichter P; Döhner H Ann Oncol; 2000; 11 Suppl 1():127-30. PubMed ID: 10707794 [TBL] [Abstract][Full Text] [Related]
11. Ataxia-telangiectasia and T-cell leukemias: no evidence for somatic ATM mutation in sporadic T-ALL or for hypermethylation of the ATM-NPAT/E14 bidirectional promoter in T-PLL. Luo L; Lu FM; Hart S; Foroni L; Rabbani H; Hammarström L; Yuille MR; Catovsky D; Webster AD; Vorechovský I Cancer Res; 1998 Jun; 58(11):2293-7. PubMed ID: 9622061 [TBL] [Abstract][Full Text] [Related]
15. Biallelic mutations in the ATM gene in T-prolymphocytic leukemia. Stilgenbauer S; Schaffner C; Litterst A; Liebisch P; Gilad S; Bar-Shira A; James MR; Lichter P; Döhner H Nat Med; 1997 Oct; 3(10):1155-9. PubMed ID: 9334731 [TBL] [Abstract][Full Text] [Related]
16. Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma. Fang NY; Greiner TC; Weisenburger DD; Chan WC; Vose JM; Smith LM; Armitage JO; Mayer RA; Pike BL; Collins FS; Hacia JG Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5372-7. PubMed ID: 12697903 [TBL] [Abstract][Full Text] [Related]
17. Cryptic deletion involving the ATM locus at 11q22.3 approximately q23.1 in B-cell chronic lymphocytic leukemia and related disorders. Eclache V; Caulet-Maugendre S; Poirel HA; Djemai M; Robert J; Lejeune F; Raphaël M Cancer Genet Cytogenet; 2004 Jul; 152(1):72-6. PubMed ID: 15193446 [TBL] [Abstract][Full Text] [Related]
18. ATM mutations in B-cell chronic lymphocytic leukemia. Bullrich F; Rasio D; Kitada S; Starostik P; Kipps T; Keating M; Albitar M; Reed JC; Croce CM Cancer Res; 1999 Jan; 59(1):24-7. PubMed ID: 9892178 [TBL] [Abstract][Full Text] [Related]
19. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance. Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464 [TBL] [Abstract][Full Text] [Related]